Lipidor Ab (Sweden) Today
LIPI Stock | SEK 0.13 0.01 8.33% |
Performance7 of 100
| Odds Of DistressOver 57
|
Lipidor Ab is selling for under 0.13 as of the 28th of November 2024; that is 8.33 percent increase since the beginning of the trading day. The stock's last reported lowest price was 0.12. Lipidor Ab has over 57 % chance of experiencing financial distress in the next 2 years of operation and did not have a very good performance during the last 90 trading days. Equity ratings for Lipidor Ab are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of October 2024 and ending today, the 28th of November 2024. Click here to learn more.
Lipidor AB , a pharmaceutical development company, engages in the development of drugs for the treatment of psoriasis, bacterial skin infections, and atopic dermatitis. Lipidor AB was founded in 2009 and is based in Stockholm, Sweden. Lipidor AB is traded on Stockholm Stock Exchange in Sweden.. The company has 28.98 M outstanding shares. More on Lipidor Ab
Moving against Lipidor Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Lipidor Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Lipidor Ab's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Lipidor Ab or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Chief Executive Officer | Ola Holmlund |
Business Concentration | Drug Manufacturers—General, Healthcare (View all Sectors) |
Lipidor Ab (LIPI) is traded on Stockholm Exchange in Sweden and employs 6 people. The company currently falls under 'Micro-Cap' category with a current market capitalization of 19.86 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Lipidor Ab's market, we take the total number of its shares issued and multiply it by Lipidor Ab's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Lipidor Ab operates under Healthcare sector and is part of Drug Manufacturers—General industry. The entity has 28.98 M outstanding shares.
Lipidor Ab has accumulated about 53.13 M in cash with (13.38 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.87, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Lipidor Ab Probability Of Bankruptcy
Ownership AllocationLipidor Ab maintains a total of 28.98 Million outstanding shares. Lipidor Ab holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Lipidor Ownership Details
Lipidor Ab Risk Profiles
Although Lipidor Ab's alpha and beta are two of the key measurements used to evaluate Lipidor Ab's performance over the market, the standard measures of volatility play an important role as well.
Mean Deviation | 4.47 | |||
Semi Deviation | 3.92 | |||
Standard Deviation | 6.14 | |||
Variance | 37.65 |
Lipidor Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Lipidor Ab without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Earnings Calls Now
Earnings CallsCheck upcoming earnings announcements updated hourly across public exchanges |
All Next | Launch Module |
Lipidor Ab Corporate Management
Elected by the shareholders, the Lipidor Ab's board of directors comprises two types of representatives: Lipidor Ab inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Lipidor. The board's role is to monitor Lipidor Ab's management team and ensure that shareholders' interests are well served. Lipidor Ab's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Lipidor Ab's outside directors are responsible for providing unbiased perspectives on the board's policies.
Charlotta Ekman | Chief Officer | Profile | |
Olle Holmertz | Founder Controller | Profile | |
Ola Flink | Independent Chairman of the Board | Profile | |
Gunilla Lundmark | Independent Director | Profile | |
Per Nilsson | Director | Profile | |
Fredrik Sjovall | Independent Director | Profile | |
Jan Holmback | Research Director | Profile |
Additional Tools for Lipidor Stock Analysis
When running Lipidor Ab's price analysis, check to measure Lipidor Ab's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lipidor Ab is operating at the current time. Most of Lipidor Ab's value examination focuses on studying past and present price action to predict the probability of Lipidor Ab's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lipidor Ab's price. Additionally, you may evaluate how the addition of Lipidor Ab to your portfolios can decrease your overall portfolio volatility.